Latent Tuberculosis Infection and Subclinical Coronary Atherosclerosis in Peru and Uganda
Authors:
Open Access
- 3 January 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 73 (9) , e3384-e3390
Abstract
Tuberculosis (TB) has been linked to an increased risk of atherosclerotic cardiovascular disease (ASCVD). We assessed whether latent TB infection (LTBI) is associated with subclinical coronary atherosclerosis in 2 TB-prevalent areas. We analyzed cross-sectional data from studies conducted in Lima, Peru, and Kampala, Uganda. Individuals ≥40 years old were included. We excluded persons with known history of ASCVD events or active TB. Participants underwent QuantiFERON-TB (QFT) testing to define LTBI and computed tomography angiography to examine coronary atherosclerosis. A Coronary Artery Disease–Reporting Data System (CAD-RADS) score ≥3 defined obstructive CAD (plaque causing ≥50% stenosis). 113 and 91 persons with and without LTBI, respectively, were included. There were no significant differences between LTBI and non-LTBI participants in terms of age (median [interquartile range]; 56 [51–62] vs 55 [49–64] years; P = .829), male sex (38% vs 42%; P = .519), or 10-year ASCVD risk scores (7.1 [3.2–11.7] vs 6.1 [2.8–1.8]; P = .533). CAD prevalence (any plaque) was similar between groups (29% vs 24%; P = .421). Obstructive CAD was present in 9% of LTBI and 3% of non-LTBI individuals (P = .095). LTBI was associated with obstructive CAD after adjusting for ASCVD risk score, HIV status, and study site (adjusted OR, 4.96; 95% CI, 1.05–23.44; P = .043). Quantitative QFT TB antigen minus Nil interferon-γ responses were associated with obstructive CAD (adjusted OR, 1.2; 95% CI, 1.03–1.41; P = .022). LTBI was independently associated with an increased likelihood of subclinical obstructive CAD. Our data indicate that LTBI is a nontraditional correlate of ASCVD risk.Keywords
Funding Information
- National Center for Advancing Translational Sciences (KL2 TR001426)
- National Heart, Lung, and Blood Institute (K23 HL123341)
- National Institute of Allergy and Infectious Diseases (UM1AI069501)
This publication has 38 references indexed in Scilit:
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular RiskCirculation, 2014
- T Regulatory Cells and Immune Activation in Mycobacterium tuberculosis Infection and the Effect of Preventive TherapyScandinavian Journal of Immunology, 2011
- Tuberculosis and the Risk of Ischemic StrokeStroke, 2010
- The spectrum of latent tuberculosis: rethinking the biology and intervention strategiesNature Reviews Microbiology, 2009
- Prognostic Value of Coronary Computed Tomographic Angiography for Prediction of Cardiac Events in Patients With Suspected Coronary Artery DiseaseJACC: Cardiovascular Imaging, 2009
- SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiographyJournal of Cardiovascular Computed Tomography, 2009
- Prognostic Value of Multidetector Coronary Computed Tomographic Angiography for Prediction of All-Cause MortalityJACC, 2007
- Disseminated tuberculosis in interferon gamma gene-disrupted mice.Journal of Experimental Medicine, 1993
- Quantification of coronary artery calcium using ultrafast computed tomographyJACC, 1990
- A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart AssociationCirculation, 1975